As of December 31, 2025, Roche Bobois SA carries a market capitalization of 314.85M, placing it among publicly traded companies globally. Its enterprise value stands at 472.57M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 314.85M |
| Enterprise Value | 472.57M |
Roche Bobois SA's next confirmed earnings release is scheduled for March 25, 2027.
| Earnings Date | 3/25/2027 |
As of December 31, 2025, Roche Bobois SA has 10.09M shares outstanding.
| Shares Outstanding | 10.09M |
These figures are as of December 31, 2025.
| PB Ratio | 3.42 |
| P/TBV Ratio | 6.46 |
As of December 31, 2025, Roche Bobois SA maintains a current ratio of 0.90, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.90 |
| Quick Ratio | 0.24 |
| Debt / Equity | 213.37 |
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 1,131.50 |
As of the close on October 22, 2026, Roche Bobois SA's stock has declined approximately 66.21% over the past 52 weeks. The 50-day moving average sits at 18.64, while the 200-day moving average is 23.56.
| 52-Week Price Change | -66.21% |
| 50-Day Moving Average | 18.64 |
| 200-Day Moving Average | 23.56 |
As of December 31, 2025, Roche Bobois SA holds 46.85M in cash and equivalents against 201.89M in total debt, resulting in a net debt position of -5.09M. Total book value stands at 91.95M, with working capital of -18.51M providing operational flexibility.
| Cash & Cash Equivalents | 46.85M |
| Total Debt | 201.89M |
| Net Debt | -5.09M |
| Equity (Book Value) | 91.95M |
| Book Value Per Share | 9.11 |
| Working Capital | -18.51M |
Already premium?